CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2A, Double-blind, Placebo-controlled, Multiple-dose Escalation Study to Evaluate Safety, Pharmacokinetics and Efficacy of Intravenously Administered Ganaxolone in Women With Postpartum Depression

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03228394
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:04.291274+00:00
Published At: 2023-02-08T00:00:00+00:00
Record Updated At: 2023-07-19
Results Posted At: 2023-02-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Depression", "Depressive Disorder", "Depression, Postpartum", "Behavioral Symptoms", "Mood Disorders", "Mental Disorders", "Puerperal Disorders", "Pregnancy Complications", "Postpartum", "PPD"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-07-19"
protocolSection.identificationModule.nctId: "NCT03228394"
protocolSection.identificationModule.officialTitle: "A Phase 2A, Double-blind, Placebo-controlled, Multiple-dose Escalation Study to Evaluate Safety, Pharmacokinetics and Efficacy of Intravenously Administered Ganaxolone in Women With Postpartum Depression"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-02-08"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.